GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genotech Corp (XKRX:066830) » Definitions » Gross Margin %

Genotech (XKRX:066830) Gross Margin % : 39.81% (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Genotech Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Genotech's Gross Profit for the six months ended in Dec. 2023 was ₩1,095 Mil. Genotech's Revenue for the six months ended in Dec. 2023 was ₩2,750 Mil. Therefore, Genotech's Gross Margin % for the quarter that ended in Dec. 2023 was 39.81%.


The historical rank and industry rank for Genotech's Gross Margin % or its related term are showing as below:

XKRX:066830' s Gross Margin % Range Over the Past 10 Years
Min: 13.89   Med: 52.23   Max: 71.52
Current: 39.81


During the past 9 years, the highest Gross Margin % of Genotech was 71.52%. The lowest was 13.89%. And the median was 52.23%.

XKRX:066830's Gross Margin % is ranked worse than
70.89% of 749 companies
in the Biotechnology industry
Industry Median: 60.63 vs XKRX:066830: 39.81

Genotech had a gross margin of 39.81% for the quarter that ended in Dec. 2023 => Competition eroding margins

The 5-Year average Growth Rate of Gross Margin for Genotech was 0.20% per year.


Genotech Gross Margin % Historical Data

The historical data trend for Genotech's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genotech Gross Margin % Chart

Genotech Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only 52.23 67.47 71.52 63.44 39.81

Genotech Semi-Annual Data
Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only 52.23 67.47 71.52 63.44 39.81

Competitive Comparison of Genotech's Gross Margin %

For the Biotechnology subindustry, Genotech's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genotech's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genotech's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Genotech's Gross Margin % falls into.



Genotech Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Genotech's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=1094.8 / 2750.326
=(Revenue - Cost of Goods Sold) / Revenue
=(2750.326 - 1655.51) / 2750.326
=39.81 %

Genotech's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=1094.8 / 2750.326
=(Revenue - Cost of Goods Sold) / Revenue
=(2750.326 - 1655.51) / 2750.326
=39.81 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Genotech  (XKRX:066830) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Genotech had a gross margin of 39.81% for the quarter that ended in Dec. 2023 => Competition eroding margins


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Genotech Gross Margin % Related Terms

Thank you for viewing the detailed overview of Genotech's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Genotech (XKRX:066830) Business Description

Traded in Other Exchanges
N/A
Address
26-69, Gajeongbuk-ro, Yuseong-gu, Daejeon, KOR, 305-343
Genotech Corp is engaged in manufacturing basic pharmaceutical substances and biological agents.

Genotech (XKRX:066830) Headlines

No Headlines